SMTL ID : 5kkn.2 (1 other biounit)

Crystal structure of human ACC2 BC domain in complex with ND-646, the primary amide of ND-630

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x 6U3: 2-[1-[(2~{R})-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-bis(oxidanylidene)thieno[2,3-d]pyrimidin-3-yl]-2-methyl-propanamide(Non-covalent)

6U3.1: 14 residues within 4Å: Chain A: I.50, K.54, R.57, R.61, V.367, P.370, E.373, M.374, V.428, N.459, W.461, F.484, S.485, W.486 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:K.54, A:M.374, A:V.428, A:V.428, A:W.461, A:F.484, A:W.486 Hydrogen bonds: A:R.57, A:R.57, A:R.61 pi-Stacking: A:W.461, A:W.461, A:W.461 pi-Cation interactions: A:K.54, A:K.54

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Harriman, G. et al., Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats. Proc.Natl.Acad.Sci.USA (2016)

Release Date

2016-07-13

Peptides

Acetyl-CoA carboxylase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Acetyl-CoA carboxylase 2

Related Entries With Identical Sequence